Covid vaccine maker Novavax says it may not survive | CNN Business

The Gaithersburg, Maryland-based company said its forecast “is subject to significant uncertainty,” particularly with regard to future sales and funding from the US government, the company said in its latest earnings report after the closing bell Tuesday. “Given these uncertainties, substantial doubt exists regarding our ability to continue as a going concern,” the company added. Shares of Novavax\n \n plunged more than 25% in early morning trading to a new multi-year low of under $7.

Despite this, Novavax’s new CEO expressed optimism about the company’s prospects. “Much has been achieved over the past three years, and based on the foundation that has been laid to date, I believe that Novavax has significant potential for a bright future,” said Novavax CEO John Jacobs, a veteran biotech executive who joined the company in January. Still, Jacobs conceded that Novavax faces numerous daunting challenges.

Just another money maker from the biowarfare

BECAUSE IT'S POISON, KILLING CHILDREN? JUST A GUESS

They ought to sue Republican trump worshipping RINO'S in the GOP for unsubstantiated or unproven killer vaccine conspiracies. I wonder how many died from Covid afraid to get vaccinated! If these companies have nothing to hide then sue and save more lives!

Please save the traditional vaccine platform

They invested in FTX?

This is great news!!!! F big pharma.

Good.

i remember this company being meme stocked all over this website

Österreich Neuesten Nachrichten, Österreich Schlagzeilen

Similar News:Sie können auch ähnliche Nachrichten wie diese lesen, die wir aus anderen Nachrichtenquellen gesammelt haben.

Video: Why the 4-day work week isn't for everyone on CNN Nightcap | CNN BusinessBloomberg Work Shift Commentator Julia Hobsbawm tells 'Nightcap's' Jon Sarlin the four-day work week is not a 'one size fits all' because some workplaces may not benefit from the shorter work week. For more, watch the full Nightcap episode here.
Herkunft: ALNewsNetwork - 🏆 583. / 51 Weiterlesen »

Novavax raises doubts about its ability to remain in businessCOVID-19 vaccine maker Novavax Inc on Tuesday raised doubts about its ability to remain in business and announced plans to slash spending as it works to prepare for a fall vaccination campaign. Did they mention the dreaded 'going concerns'?
Herkunft: Reuters - 🏆 2. / 97 Weiterlesen »